BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36087543)

  • 1. Oncologic management of ampullary cancer: International survey among surgical and medical oncologists.
    de Jong EJM; Lemmers DHL; Benedetti Cacciaguerra A; Bouwense SAW; Geurts SME; Tjan-Heijnen VCG; Valkenburg-van Iersel LBJ; Wilmink JW; Besselink MG; Abu Hilal M; de Vos-Geelen J
    Surg Oncol; 2022 Sep; 44():101841. PubMed ID: 36087543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of Ampullary Adenocarcinoma].
    Shin DW
    Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma.
    Cheng J; Mao Y; Hong W; Hu W; Shu P; Huang K; Yu J; Jiang M; Li L; Wang W; Ni D; Li S
    J Transl Med; 2022 Jun; 20(1):272. PubMed ID: 35705951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes.
    Tesarikova J; Skalicky P; Kurfurstova D; Svebisova H; Urban O; Falt P; Zapletalova J; Klos D; Lovecek M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):290-296. PubMed ID: 34012147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
    Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
    J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for true ampullary cancer: a systematic review.
    Bonet M; Rodrigo A; Vázquez S; Carrizo V; Vilardell F; Mira M
    Clin Transl Oncol; 2020 Aug; 22(8):1407-1413. PubMed ID: 31927720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
    Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
    Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampullary cancer: an overview.
    Ahn DH; Bekaii-Saab T
    Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.
    Michelassi F; Erroi F; Dawson PJ; Pietrabissa A; Noda S; Handcock M; Block GE
    Ann Surg; 1989 Oct; 210(4):544-54; discussion 554-6. PubMed ID: 2679459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and external validation of a prediction model for survival in patients with resected ampullary adenocarcinoma.
    Moekotte AL; van Roessel S; Malleo G; Rajak R; Ecker BL; Fontana M; Han HS; Rabie M; Roberts KJ; Khalil K; White SA; Robinson S; Halimi A; Zarantonello L; Fusai GK; Gradinariu G; Alseidi A; Bonds M; Dreyer S; Jamieson NB; Mowbray N; Al-Sarireh B; Mavroeidis VK; Soonawalla Z; Napoli N; Boggi U; Kent TS; Fisher WE; Tang CN; Bolm L; House MG; Dillhoff ME; Behrman SW; Nakamura M; Ball CG; Berger AC; Christein JD; Zureikat AH; Salem RR; Vollmer CM; Salvia R; Besselink MG; Abu Hilal M; ; Aljarrah R; Barrows C; Cagigas MN; Lai ECH; Wellner U; Aversa J; Dickson PV; Ohtsuka T; Dixon E; Zheng R; Kowalski S; Freedman-Weiss M
    Eur J Surg Oncol; 2020 Sep; 46(9):1717-1726. PubMed ID: 32624291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current surgical treatment of extra-ampullary duodenal tumor].
    Okada KI; Yamaue H
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(2):126-131. PubMed ID: 35153261
    [No Abstract]   [Full Text] [Related]  

  • 16. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
    Tsao JI; Rossi RL; Lowell JA
    Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
    Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
    BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
    Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
    Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.